Keymed Biosciences Inc. Stock OTC Markets
Stocks
KEYBF
KYG5252B1023
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
OTC Markets
|
5-day change | 1st Jan Change | ||
| - USD | -.--% |
|
-.--% | - |
| Market Cap | 19.51B 2.91B 2.6B 2.43B 2.2B 4.15B 281B 4.18B 29.14B 11.39B 143B 10.92B 10.69B 460B | P/E 2026 * |
24.2x | P/E 2027 * | 1,362x |
|---|---|---|---|---|---|
| Enterprise Value | 18.38B 2.74B 2.45B 2.29B 2.08B 3.91B 265B 3.94B 27.46B 10.73B 135B 10.29B 10.07B 434B | EV / Sales 2026 * |
10.9x | EV / Sales 2027 * | 8.65x |
| Free-Float |
74.84% | Yield 2026 * |
-
| Yield 2027 * | - |
| Manager | Title | Age | Since |
|---|---|---|---|
Bo Chen
CEO | Chief Executive Officer | 52 | 23/04/2018 |
Changyu Wang
PRN | Corporate Officer/Principal | 61 | 03/03/2021 |
Pak Yu Tam
SEC | Corporate Secretary | - | 29/03/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Bo Chen
CHM | Chairman | 52 | 23/04/2018 |
Changyu Wang
BRD | Director/Board Member | 61 | 03/03/2021 |
Gang Xu
BRD | Director/Board Member | 52 | 21/06/2018 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | - | - | 2.99B | |
| +4.16% | +4.16% | +49.37% | +94.17% | 74.69B | |
| +0.46% | -0.97% | +23.51% | +79.34% | 58.81B | |
| +0.17% | +0.35% | +6.85% | +34.55% | 48.45B | |
| +0.50% | -2.14% | +331.33% | +702.20% | 42.84B | |
| -0.72% | -3.99% | +28.50% | +29.94% | 42.79B | |
| +0.34% | -0.52% | +6.56% | +109.35% | 41.25B | |
| -0.11% | +1.96% | +9.19% | +52.66% | 31.13B | |
| -0.50% | -3.10% | -10.19% | -14.35% | 24.05B | |
| -3.32% | -10.86% | -37.32% | +316.28% | 22.98B | |
| Average | +0.10% | -2.37% | +45.31% | +156.02% | 43B | |
| Weighted average by Cap. | +0.66% | -1.80% | +52.38% | +149.38% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.68B 251M 224M 209M 190M 358M 24.27B 360M 2.51B 982M 12.34B 942M 921M 39.67B | 2.15B 320M 286M 267M 242M 456M 30.96B 460M 3.21B 1.25B 15.75B 1.2B 1.18B 50.62B |
| Net income | 672M 100M 89.62M 83.61M 75.95M 143M 9.7B 144M 1B 393M 4.93B 377M 368M 15.86B | -14.18M -2.11M -1.89M -1.76M -1.6M -3.02M -205M -3.04M -21.18M -8.28M -104M -7.94M -7.77M -334M |
| Net Debt | -1.12B -167M -150M -140M -127M -239M -16.2B -241M -1.68B -655M -8.24B -629M -615M -26.49B | -935M -139M -125M -116M -106M -199M -13.49B -200M -1.4B -546M -6.86B -524M -512M -22.06B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 2162 Stock
- KEYBF Stock
Select your edition
All financial news and data tailored to specific country editions
